Work

Neoadjuvant combination immunotherapy with ipilimumab (3 mg/kg or 10mg/kg) and high dose IFN-a2b in locally/regionally advanced melanoma.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.9585

Authors: Ahmad A. Tarhini, Zahra Rahman, Yan Lin, Priyanka Vallabhaneni, Hussein Abdul-Hassan Tawbi, Andrew Gnan, Amanda McFadden, Amy Rose, Chelsea Pruckner, Melissa Wilson, James F. Pingpank, Matthew Peter Holtzman, Robert L. Ferris, Uma N. M. Rao, John M. Kirkwood

Institutions: UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2528111205

Cites:

Cited by: 7

Related to: 10